MediWound Ltd. Quarterly Research And Development Expense in USD from Q2 2017 to Q2 2024

Taxonomy & unit
ifrs-full: USD
Summary
MediWound Ltd. annual/quarterly Research And Development Expense history and growth rate from Q2 2017 to Q2 2024.
  • MediWound Ltd. Research And Development Expense for the quarter ending June 30, 2024 was $1.9M, a 6.23% decline year-over-year.
  • MediWound Ltd. annual Research And Development Expense for 2024 was $8.88M, a 18.9% increase from 2023.
  • MediWound Ltd. annual Research And Development Expense for 2023 was $7.47M, a 26.7% decline from 2022.
  • MediWound Ltd. annual Research And Development Expense for 2022 was $10.2M, a 0.73% decline from 2021.
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.9M -$126K -6.23% Apr 1, 2024 Jun 30, 2024 6-K 2024-08-14
Q2 2023 $2.02M -$167K -7.62% Apr 1, 2023 Jun 30, 2023 6-K 2024-08-14
Q2 2022 $2.19M -$465K -17.5% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-15
Q2 2021 $2.66M +$1.04M +64.8% Apr 1, 2021 Jun 30, 2021 6-K 2022-08-09
Q2 2020 $1.61M +$1.44M +837% Apr 1, 2020 Jun 30, 2020 6-K 2021-08-10
Q2 2019 $172K -$1.36M -88.8% Apr 1, 2019 Jun 30, 2019 6-K/A 2020-10-30
Q2 2018 $1.54M -$128K -7.69% Apr 1, 2018 Jun 30, 2018 6-K 2019-08-12
Q2 2017 $1.66M Apr 1, 2017 Jun 30, 2017 6-K 2018-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.